Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2000
05/04/2000WO2000024773A2 Inhibition of transglutaminase-mediated microbial infection of a mammalian host
05/04/2000WO2000024772A2 Scorpion toxins
05/04/2000WO2000024771A2 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same
05/04/2000WO2000024770A2 Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
05/04/2000WO2000024769A2 Process for recovering heterologous polypeptide from bacterial refractile particles
05/04/2000WO2000024768A2 Genes integrating signal transduction pathways
05/04/2000WO2000024767A2 Human membrane associated protein 'zsig24' and encoding gene as marker for metabolic disease
05/04/2000WO2000024766A2 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
05/04/2000WO2000024765A2 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000WO2000024759A1 Systemic delivery of gene products via skin
05/04/2000WO2000024758A1 ISOLATED NUCLEIC ACID MOLECULES WHICH ENCODE T CELL INDUCIBLE FACTORS (TIFs), THE PROTEINS ENCODED, AND USES THEREOF
05/04/2000WO2000024757A1 Human retinoid-like orphan receptor gamma
05/04/2000WO2000024756A1 Fibroblast growth factor receptor-5
05/04/2000WO2000024755A1 Ovary-specific genes and proteins
05/04/2000WO2000024754A1 infB POLYPEPTIDE AND POLYNUCLEOTIDES OF STREPTOCOCCUS PNEUMONIAE
05/04/2000WO2000024606A1 A coupling mechanism for a frameless trailer
05/04/2000WO2000024416A1 Remedies for bone metabolic errors
05/04/2000WO2000024412A2 Use of vegf-c or vegf-d gene or protein to prevent restenosis
05/04/2000WO2000024267A1 Gelatins with low allergenicity
05/04/2000WO2000024254A1 Compositions and methods for modulating expression within smooth muscle cells
05/04/2000WO2000024252A1 Ftsz:ftsa multimeric proteins and their uses
05/04/2000WO2000024245A1 REGULATION OF TH2 CELL ACTIVITY BY MODULATION OF NFATp AND NFAT4 ACTIVITY
05/04/2000WO2000018211A8 A novel cochlear gene coch5b2 and uses therefor
05/04/2000WO2000014255A8 REGULATION OF GENE EXPRESSION THROUGH MANIPULATION OF mRNA SPLICING AND ITS USES
05/04/2000WO2000012139B1 Hypoxia regulated genes
05/04/2000WO2000006751A3 Repressor proteins producing cell lines for the propagation of vectors
05/04/2000WO2000006743A3 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000WO2000006733A3 T cell receptor proteins, nucleic acid molecules, and uses thereof
05/04/2000WO2000006732A3 Polynucleotide encoding an autoantigen associated with endometriosis
05/04/2000WO2000006730A3 Human cytoskeletal proteins
05/04/2000WO2000006728A3 Phosphorylation effectors
05/04/2000WO2000006727A3 Human epidermal proteins hepi-1 to hepi-6
05/04/2000WO2000006187A3 Modulation of apoptosis
05/04/2000WO2000005367A3 Human proteins having hydrophobic domains and dnas encoding these proteins
05/04/2000WO2000005263A3 Compounds for use in the treatment of inflammation
05/04/2000WO2000003009A3 Genes for the biosynthesis of anticapsin and bacilysine, their isolation and their use
05/04/2000WO2000002917A3 Compounds and methods for modulating cadherin-mediated functions
05/04/2000WO2000002909A3 Amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins
05/04/2000WO2000002897B1 Delta cleavage products and methods based thereon
05/04/2000WO2000000614A3 NOVEL ANTIGENS OF $i(HELICOBACTER PYLORI)
05/04/2000WO1999067286A9 Novel staphylococcus peptides for bacterial interference
05/04/2000WO1999066959A3 Compositions and methods for delivery of genetic material for altering neuronal growth, regeneration, and survival
05/04/2000WO1999062945A9 Peptide antigens for detection of hiv, hcv and other microbial infections
05/04/2000WO1999062934A9 Interferon receptor hkaef92
05/04/2000WO1999062315A3 Method for altering the activity of proteins of the pka signaling pathway
05/04/2000WO1999061619A8 Cell cycle genes, proteins and uses thereof
05/04/2000WO1999061580A8 Modification of cereal grain hardness via expression of puroindoline proteins
05/04/2000WO1999060146A9 Adeno-associated virus vectors and uses thereof
05/04/2000WO1999054474A3 Bacterial yiha polypeptide family
05/04/2000WO1999053021A9 Cell differentiation/proliferation and maintenance factor and uses thereof
05/04/2000WO1999052944A8 G-protein coupled receptors
05/04/2000WO1999051781A9 Hepatitis c virus ns5b compositions and methods of use thereof
05/04/2000WO1999047660A9 Retroviral packaging cell line
05/04/2000DE19856882C1 New spermatogenesis protein useful for investigation and modulation of spermatogenesis, particularly for diagnosis and treatment of spermatogenesis disorders
05/04/2000DE19850429A1 Fragmente Fragments
05/04/2000DE19850015A1 Proteine der Stomatinfamilie und ihre Verwendung als Zielproteine für die Schm erztherapie Erztherapie proteins of the Stomatinfamilie and their use as target proteins for jewelry
05/04/2000DE19835910C1 Gen isoliert auf dem kurzen Arm des menschlichen Chromosoms 17 Gene isolated on the short arm of human chromosome 17
05/04/2000CA2763066A1 Mn gene and protein
05/04/2000CA2349211A1 Prv-1 gene and the use thereof
05/04/2000CA2348989A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000CA2348827A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000CA2348747A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000CA2348730A1 Novel g protein coupled receptor protein and dna thereof
05/04/2000CA2348563A1 Compositions and methods for treating polycystic kidney disease
05/04/2000CA2348431A1 Interleukin-1 homolog zil1a4
05/04/2000CA2348430A1 Ovary-specific genes and proteins
05/04/2000CA2348046A1 Lysine-rich statherin protein
05/04/2000CA2347993A1 Method for producing in vivo proteins chemically diversified by incorporating non-standard amino acids
05/04/2000CA2347983A1 Inhibition of transglutaminase-mediated microbial infection of a mammalian host
05/04/2000CA2347679A1 Human gene marker for metabolic disease
05/04/2000CA2347655A1 Growth factor related molecules
05/04/2000CA2347294A1 Novel g protein coupled receptor protein, dna and its ligand
05/04/2000CA2347293A1 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same
05/04/2000CA2347134A1 Maize kin17 orthologues and uses thereof
05/04/2000CA2347107A1 Bone-pathobolism treating agent
05/04/2000CA2347075A1 Cdna sequence and genomic organization for a 59.4 kda neuronal-specific 7 transmembrane protein (pneu60)
05/04/2000CA2347068A1 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
05/04/2000CA2346996A1 Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
05/04/2000CA2345902A1 Apomixis conferred by expression of serk interacting proteins
05/04/2000CA2341062A1 Scorpion toxins
05/04/2000CA2316407A1 Groups of genes expressed in human monocytes and human macrophages
05/03/2000EP0997529A2 Feline immunodeficiency virus strain FIV-141 and uses thereof
05/03/2000EP0997528A1 Streptomyces avermitilis regulatory genes for increased avermectin production
05/03/2000EP0997477A2 MHC complexes and uses thereof
05/03/2000EP0997476A2 Antibodies to a mammalian Langerhans cell antigen and their uses
05/03/2000EP0997475A1 Tumor necrosis factor inhibitory protein TIP-B1 and method of using same
05/03/2000EP0997459A1 Intermediates for preparing retroviral protease inhibiting compounds
05/03/2000EP0997152A1 Remedies for lymphocytic tumors
05/03/2000EP0997151A2 Method for administering insulinotropic peptides
05/03/2000EP0996858A2 Interactions of atm, atr or dna-pk with p53
05/03/2000EP0996857A2 Cancer associated nucleic acids and polypeptides
05/03/2000EP0996855A1 Improved biosensor involving the use of optically sensitive moieties
05/03/2000EP0996739A2 Improvments in gene therapy using compositions comprising a polynucleotide and a nuclease inhibitor or interleukin-10
05/03/2000EP0996731A2 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses
05/03/2000EP0996730A1 Nucleic acid vaccines encoding g protein of respiratory syncytial virus
05/03/2000EP0996729A2 Hypersensitive response elicitor fragments and uses thereof
05/03/2000EP0996727A1 Gene conferring obese phenotype
05/03/2000EP0996726A1 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof
05/03/2000EP0996725A1 Human nk-3 related prostate specific gene-1
05/03/2000EP0996724A1 Polynucleotides encoding a growth factor-like protein (as amended)
1 ... 2165 2166 2167 2168 2169 2170 2171 2172 2173 2174 2175 2176 2177 2178 2179 2180 2181 2182 2183 2184 2185 ... 2916